Asbestos causes translocation of p65 protein and increases NF-κB DNA binding activity in rat lung epithelial and pleural mesothelial cells

American Journal of Pathology

Volumn 151, Issue 2, 1997, Pages 389-401

  Janssen, Yvonne M W ^a,d   Driscoll, Kevin E ^b   Howard, Brian ^b   Quinlan, Timothy R ^a   Treadwell, Melinda ^c   Barchowsky, Aaron ^c   Mossman, Brooke T ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRYSOTILE; CROCIDOLITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; SYNAPTOTAGMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASBESTOSIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; LUNG ALVEOLUS EPITHELIUM; MALE; MESOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT;

ANIMALS; ASBESTOS; BIOLOGICAL TRANSPORT; CARCINOGENS; DNA; DNA-BINDING PROTEINS; EPITHELIUM; LUNG; MALE; MICROSCOPY, CONFOCAL; NF-KAPPA B; PLEURA; PROTEIN BINDING; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 0030762657     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Mossman BT, Bignon J, Corn M, Seaton A, Gee JBL: Asbestos: scientific developments and implications for public policy. Science 1990, 247:294-301
2. Mossman BT, Gee JBL: Medical progress: asbestos-related diseases. N Engl J Med 1989, 320:1721-1730
3. Mossman B, Kamp D, Weitzman S: Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 1996, 14:466-480
4. Griffith DE, Miller EJ, Gray LD, Idell S, Johnson AR: lnterleukin-1mediated release of interleukin-8 by asbestos-stimulated human pleural mesothelial cells. Am J Respir Cell Mol Biol 1994, 10:245-252
5. Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN: Enhanced IL-1 β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993, 150:4188-4196
6. Driscoll KE, DG Hassenbein, JM Carter, SL Kunkel, T. R: Quinlan, Mossman BT: 1995, TNF-α and increased chemokine expression in rat lung after particle exposure, Toxicol. Lett:82/83:483-489
7. Janssen YMW, Marsh JP, Absher MP, Hemenway D, Vacek PM, Leslie KO, Borm PJA, Mossman BT: Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica, J Biol Chem 1992, 267:10625-10630
8. Janssen YMW, Marsh JP, Absher MP, Gabrielson E, Borm PJA, Driscoll K, Mossman BT: Oxidant stress responses in human pleural mesothelial cells exposed to asbestos. Am J Respir Crit Care Med 1994, 149:795-802
9. -) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 1987, 47:1681-1686
10. Goodglick LA, Kane AB: Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res 1986, 46:5558-5566
11. Weitzman SA, Graceffa P: Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide, Arch Biochem Biophys 1984, 228:373-376
12. Janssen Y, Heintz N, Mossman B: Induction of c-fos and c-jun protooncogene by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res 1995, 55:2085-2089
13. Perkins RC, Scheule RK, Hamilton R, Gomes G, Freidman G, Holian A: Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Exp Lung Res 1993, 19:55-65
14. Mossman BT, Faux S, Janssen Y, Jiminez LA, Timblin C, Zanelia C, Goldberg J, Walsh E, Barchowsky A, Driscoll K: Cell signalling pathways elicited by asbestos. Environ Health Perspect 1997 (in press)
15. Anderson MT, Staal FJT, Gitler C, Herzenberg LA, Herzenberg LA: Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA 1994, 91:11527-11531
16. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M: Oxidant-sensitive and phosphorylation-dependent activation of NF-κB and AP-1 in endothelial cells. Arn J Physiol 1995, 269:L829-L836
17. 2O and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor, EMBO J 1993, 12:2005-2015
18. Janssen YMW, Barchowsky A, Treadwell M, Driscoll KE, Mossman BT: Asbestos induces nuclear factor κB(NF-κB)DNA-binding activity and NF-κB-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci USA 1995, 92:8458-8462
19. Read MA, Whitley MZ, Williams AJ, Collins T: NF-κB and IκBα: an inducible regulatory system in endothelial activation, J Exp Med 1994, 179:503-512
20. Kunsch C, Rosen CA; NF-κB subunit-specific regulation of the interleukin-8 promoter, Mol Cell Biol 1993, 13:6137-6146
21. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S: Transcription factors NF-IL6 and NF-κ synergistically activate transcription of the inflammatory cytokines. interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993, 90:10193-10197
22. O'Connell MA, Cleere R, Long A, O'Neill LA, Kelleher D: Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor α in the human T lymphoma line HuT 78. J Biol Chem 1995, 270:7399-7404
23. Autieri MW, Yue TL, Ferstein GZ, Ohlstein E: Antisense oligonucleotides to the p65 subunit of NF-κB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries, Biochem Biophys Res Commun 1995, 213:827-836
24. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996, 274:782-784
25. Wang C-Y, Mayo MW, Baldwin AS Jr: TNF- and cancer therapyinduced apoptosis: potentiation by inhibition of NF-κB. Science 1996, 274:784-787
26. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB;. Science 1996, 274:787-789
27. Devary Y, Rosette C, DiDonato JA, Karin M: NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science 1993, 261:1442-1445
28. Mohan N, Meltz ML: Induction of nuclear factor κB after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat Res 1994, 140:97-104
29. Israel A: A role for phosphorylation and degradation in the control of NF-κB activity, Trends Genet 1995, 11:203-205
30. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T: The ubiquitinproteosome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB, Cell 1994, 78:773-785
31. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers, FASEB J 1995, 9:899-909
32. Xie Q-W, Kashiwabara Y, Nathan C: Role of transcription factor NFκB/Rel in induction of nitric oxide synthase. J Biol Chem 1994, 269: 4705-4708
33. LaRosa FA, Pierce JW, Sonenshein GE: Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors. Mol Cell Biol 1994, 14:1039-1044
34. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T: NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene, J Immunol 1994, 153:2052-2063
35. Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D, Mickey R, Vacek P, Kagan E: Inhibition of lung injury, inflammation and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 1990, 141:1266-1271
36. Quinlan TR, Marsh JP, Janssen YMW, Leslie KO, Hemenway D, Vacek P, Mossman BT: Dose responsive increases in pulmonary fibrosis after inhalation of asbestos. Am J Respir Crit Care Med 1994, 150:200-206
37. Quinlan TR, BéruBé KA, Marsh JP, Janssen YMW, Taishi P, Leslie KO, Hemenway D, O'Shaughnessy PT, Vacek P, Mossman BT: Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos, Am J Pathol 1995, 147:728-739
38. BéruBé KA, Quinlan TR, Moulton G, Hemenway D, O'Shaughnessy P, Vacek P, Mossman BT: Comparative proliferative and histopathologic changes in rat lungs after inhalation of chrysotile and crocidolite asbestos. Toxicol Appl Pharmacol 1996, 137:67-74
39. Schmitz R, Baeuerle P: The p65 subunit is responsible for the strong transcription activating potential of NF-κB, EMBO J 1991, 10:3805-3817
40. Campbell WJ, Huggins CW, Wylie AG: Chemical and physical characterization of amosite, chrysotile, crocidolite, and nonfibrous tremolite for oral ingestion studies by the National Institute of Environmental Health Sciences, US Bureau of Mines Report of Investigations, No 8452, 1980
41. Hemenway DR, MacAskill SM: Design, development and test results of a horizontal flow facility. Am Ind Hyg Assoc 1982, 43:874-879
42. Driscoll KE, Carter JM, lype PT, Kumari HL, Crosby LL, Aardema MJ, Isfort RJ, Cody D, Chestnut MH, Burns JL, LeBoeuf RA: Establishment of immortalized alveolar type II epithelial cell lines from adult rats. In Vitro Cell Dev Biol Animal 1995, 31:516-527
43. Jaurand MC, Renier A, van der Meeren A, Magne J, Pinchon L, Bignon J: Rat pleural mesothelial cell in culture. In Vitro 1981, 17:98-108
44. Janssen YMW, Heintz NH, Marsh JP, Borm PJA, Mossman BT: Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibers. Am J Respir Cell Mol Biol 1994, 11:522-530
45. Staal FJ, Roederer M, Herzenberg LA, Herzenberg LA: Intracellular thiols regulate activation of nuclear factor Kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1994, 87:9943-9947
46. Brody AR, Hill LH: Interstitial accumulation of inhaled chrysotile asbestos fibers and consequent formation of microcalcifications. Am J Pathol 1982, 109:107-114
47. Holley JA, Janssen YMW, Mossman BT, Taatjes DJ: Increased manganese Superoxide dismutase protein in type II epithelial cells of rat lungs after inhalation of crocidolite asbestos or cristobalite silica. Am J Pathol 1992, 141:475-485
48. Driscoll KE, Maurer JK, Higgins J, Poynter J: Alveolar macrophage and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. J Toxicol Environ Health 1995, 46:155-169
49. Brody AR, Overby LH: Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos-exposed rats. Am J Pathol 1989, 134:133-140
50. Shatos MA, Doherty JM, Marsh JP, Mossman BT: Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species, Environ Res 1987, 48:709-714
51. Goodglick LA, Pietras LA, Kane A: Evaluation of the causal relationship between crocidolite asbestos-induced lipid peroxidation and toxicity to macrophages. Am Rev Respir Dis 1989, 139:1265-1273
52. Lund LG, Aust AE: Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DMA single-strand breaks in phi X174 RFI DMA. Carcinogenesis 1992, 13:637-642
53. Simeonova PP, Luster Ml: Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α response from alveolar macrophages. Am J Respir Cell Mol Biol 1995, 12:676-683
54. Owens MW, Grisham MB: Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolysaccharide, Am J Physiol 1993, 265:110-116
55. Flak TA, Goldman WE: Autotoxicity of nitric oxide in airway disease. Am J Respir Crit Care Med 1996, 154:5202-3206
56. Thomas G, Ando T, Verma K, Kagan E: Asbestos fibers and interferon-γ upregulate nitric oxide production in rat alveolar macrophages. Am J Respir Cell Mol Biol 1994, 11:707-715
57. Craighead JE, Abraham JL, Churg A, Green FHY, Kleinerman J, Pratt PC, Seemayer TA, Vallyathan V, Weill H: The pathology of asbestosassociated diseases of the lung and pleural cavities: diagnostic criteria and proposed grading schema, Arch Pathol Lab Med 1982, 106:544-597